newsfilter
← Latest News
Business Wire·

Humanigen's Budget Impact Model Demonstrates Lenzilumab's Potential Positive Economic Value in Hospitalized COVID-19 Patients

Overall analysis demonstrates treatment with lenzilumab may result in both clinical and economic benefits in the majority of hospitalized patients Potential clinical and economic benefits are greater in certain patient populations Humanigen,